SONA Sona Nanotech Inc.
Sona Nanotech Inc. operates as a nanotechnology life sciences company in the United States and Canada The company researchers and develops gold nanoparticles for potential therapies, including photothermal therapy, tumor targeting activity, anti-bacterial activity, and drug delivery vehicle, as well as diagnostics, such as diagnostic markers for imaging and immunoassay and biosensing. It also engages in the development of targeted hyperthermia therapy, a photo thermal therapy for the treatment of cancer tumors; and diagnostic tools comprising lateral flow assay rapid and bovine tuberculosis tests. The company was founded in 2013 and is based in Halifax, Canada.…
Industry Peers
BiotechnologyKey Statistics
About Sona Nanotech (CNSX: SONA)
›
Sona Nanotech (CNSX: SONA) is listed on the Canadian Securities Exchange, where its shares trade in CAD. It belongs to the Biotechnology industry, part of the Healthcare sector.
The shares were at 0.2600 CAD on 19 November 2026, down 54.4% over 52 weeks. Its 52-week range is 0.2400 CAD to 0.8400 CAD: the price is 69.0% below the high and 8.3% above the low.
Its market capitalisation is 31.93M CAD.
Sona Nanotech reports an operating margin of 0.0%.
Its debt exceeds its cash by 322.95K CAD. Its Piotroski F-score is 1 out of 9, a weak reading of its financial health.